我院2013-2015年辅助用药应用分析
x

请在关注微信后,向客服人员索取文件

篇名: 我院2013-2015年辅助用药应用分析
TITLE:
摘要: 目的:为临床合理使用辅助用药提供参考。方法:采用回顾性方法,对我院2013-2015年销售金额和用药频度(DDDs)排名前10位的辅助用药的销售金额、用药频度、日均费用(DDC)、排序比(B/A)等进行统计分析。结果:2013-2015年,我院辅助用药销售金额由3 295.90万元逐年增长至4 243.65万元,占药品总销售金额的比例由31.28%上升至35.22%;销售金额排序前10位的辅助用药剂型均为注射剂,品种以活血化瘀、神经营养类、免疫调节药为主,销售金额有波动,但总体呈上升趋势;DDDs排序前10位的辅助用药品种以增强组织代谢、维生素类、神经营养类、活血化瘀类为主;DDC较大的主要为注射剂,且这些药物的B/A同步性不佳,药品价格水平较高。结论:建议医院规范辅助用药的应用,以促进药物有效、经济、合理使用。
ABSTRACT: OBJECTIVE: To provide reference for rational use of adjuvant drugs in the clinic. METHODS: By retrospective method, the utilization of top 10 adjuvant in the list of consumption sum and DDDs in our hospital during 2013-2015 were analyzed statistically in respects of consumption sum, DDDs, DDC, B/A, etc. RESULTS: During 2013-2015, the consumption sum of adjuvant drugs in our hospital increased from 32 959 000 yuan to 42 436 500 yuan, and its proportion in total consumption sum increased from 31.28% to 35.22%. The top 10 adjuvant dosage forms in the list of consumption sum were injection, and varieties included activating blood circulation to dissipate blood stasis, nerve nutrition, immunoregulation drugs. The consumption sum fluctuated but was on the increase in general. Top 10 adjuvant drug types in the list of DDDs were mainly drugs for enhancing tissue metabolism, vitamins, nerve nutrition, activating blood circulation to dissipate blood stasis. In terms of DDC, main dosage form was injection; B/A of these drugs was poor and drug price was in high level.  CONCLUSIONS: It is suggested to standardize the utilization of adjuvant drugs, so as to promote the effective, economical and rational use of drugs.
期刊: 2017年第28卷第8期
作者: 路丹,卢成华
AUTHORS: LU Dan,LU Chenghua
关键字: 辅助用药;销售金额;用药频度;日均费用
KEYWORDS: Adjuvant drugs; Consumption sum; DDDs; DDC
阅读数: 461 次
本月下载数: 30 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!